These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
March 31,
2025
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number:
1-11978
The Manitowoc Company, Inc.
(Exact Name of Registrant as Specified in its Charter)
Wisconsin
39-0448110
(State or other jurisdiction
(I.R.S. Employer
of incorporation or organization)
Identification Number)
11270 West Park Place
Suite 1000
Milwaukee
,
Wisconsin
53224
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (
414
)
760-4600
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 Par Value
MTW
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☒
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
☒
As of March 31, 2025, the registrant had
35,443,463
shares of common stock, $.01 par value per share, outstanding.
PART I. FINANCI
AL INFORMATION
Item 1. Financ
ial Statements
THE MANITOWOC COMPANY, INC.
Condensed Consolidated S
tatements of Operations
For the three months ended March 31, 2025 and 2024
(Unaudited)
(In millions, except per share and share amounts)
Three Months Ended
March 31,
2025
2024
Net sales
$
470.9
$
495.1
Cost of sales
381.1
402.6
Gross profit
89.8
92.5
Operating costs and expenses:
Engineering, selling, and administrative expenses
82.9
76.0
Amortization of intangible assets
0.8
0.7
Restructuring expense
0.8
0.6
Total operating costs and expenses
84.5
77.3
Operating income
5.3
15.2
Other income (expense):
Interest expense
(
8.7
)
(
9.2
)
Amortization of deferred financing fees
(
0.4
)
(
0.3
)
Other income (expense) - net
(
5.0
)
0.7
Total other expense
(
14.1
)
(
8.8
)
Income (loss) before income taxes
(
8.8
)
6.4
Provision (benefit) for income taxes
(
2.5
)
1.9
Net income (loss)
$
(
6.3
)
$
4.5
Per Share Data and Share Amounts
Basic net income (loss) per common share
$
(
0.18
)
$
0.13
Diluted net income (loss) per common share
$
(
0.18
)
$
0.12
Weighted average shares outstanding - basic
35,273,783
35,265,449
Weighted average shares outstanding - diluted
35,273,783
36,060,640
The accompanying notes are an integral part to these Condensed Consolidated Financial Statements.
2
THE MANITOWOC COMPANY, INC.
Condensed Consolidated Statement
s of Comprehensive Income (Loss)
For the three months ended March 31, 2025 and 2024
(Unaudited)
(In millions)
Three Months Ended
March 31,
2025
2024
Net income (loss)
$
(
6.3
)
$
4.5
Other comprehensive income (loss), net of income tax:
Unrealized gains (losses) on derivatives, net of income tax
provision of $
0.8
and $
0.0
, respectively
2.5
(
1.6
)
Employee pension and postretirement benefit income (expense), net of
income tax benefit of $
0.0
and $
0.0
, respectively
(
0.4
)
0.1
Foreign currency translation adjustments, net of income tax (provision) benefit
of $(
2.7
) and $
0.6
, respectively
15.8
(
11.0
)
Total other comprehensive income (loss), net of income tax
17.9
(
12.5
)
Comprehensive income (loss)
$
11.6
$
(
8.0
)
The accompanying notes are an integral part to these Condensed Consolidated Financial Statements.
3
THE MANITOWOC COMPANY, INC.
Condensed Consolida
ted Balance Sheets
As of March 31, 2025 and December 31, 2024
(Unaudited)
(In millions, except par value and share amounts)
March 31,
2025
December 31,
2024
Assets
Current Assets:
Cash and cash equivalents
$
41.4
$
48.0
Accounts receivable, less allowances of $
5.4
and $
5.9
, respectively
267.9
260.3
Inventories - net
701.7
609.4
Other current assets
43.5
41.2
Total current assets
1,054.5
958.9
Property, plant, and equipment - net
344.4
346.2
Operating lease right-of-use assets
67.5
59.3
Goodwill
78.0
77.8
Intangible assets - net
122.4
118.5
Other non-current assets
97.0
99.3
Total assets
$
1,763.8
$
1,660.0
Liabilities and Stockholders' Equity
Current Liabilities:
Accounts payable and accrued expenses
$
456.0
$
389.4
Customer advances
24.9
18.0
Short-term borrowings and current portion of long-term debt
17.6
13.1
Product warranties
38.3
37.0
Other liabilities
18.0
16.8
Total current liabilities
554.8
474.3
Non-Current Liabilities:
Long-term debt
381.4
377.1
Operating lease liabilities
54.6
47.0
Deferred income taxes
2.2
2.1
Pension obligations
48.1
47.1
Postretirement health and other benefit obligations
4.5
4.7
Long-term deferred revenue
17.1
17.5
Other non-current liabilities
49.5
50.1
Total non-current liabilities
557.4
545.6
Commitments and contingencies
(Note 18)
Stockholders' Equity:
Preferred stock (
3,500,000
shares authorized of $
.01
par value;
none
outstanding)
—
—
Common stock (
75,000,000
shares authorized,
40,793,983
shares issued,
35,443,463
and
35,134,245
shares outstanding, respectively)
0.4
0.4
Additional paid-in capital
611.3
615.1
Accumulated other comprehensive loss
(
89.7
)
(
107.6
)
Retained earnings
193.0
199.3
Treasury stock, at cost (
5,350,520
and
5,659,738
shares, respectively)
(
63.4
)
(
67.1
)
Total stockholders' equity
651.6
640.1
Total liabilities and stockholders' equity
$
1,763.8
$
1,660.0
The accompanying notes are an integral part to these Condensed Consolidated Financial Statements.
4
THE MANITOWOC COMPANY, INC.
Condensed Consolidated S
tatements of Cash Flows
For the three months ended March 31, 2025 and 2024
(Unaudited)
(In millions)
Three Months Ended
March 31,
2025
2024
Cash Flows from Operating Activities:
Net income (loss)
$
(
6.3
)
$
4.5
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Depreciation expense
14.8
14.7
Amortization of intangible assets
0.8
0.7
Stock-based compensation expense
2.6
3.7
Amortization of deferred financing fees
0.4
0.3
Loss on sale of property, plant, and equipment
0.1
0.2
Changes in operating assets and liabilities:
Accounts receivable
(
3.6
)
(
15.3
)
Inventories
(
66.0
)
(
89.1
)
Other assets
1.2
2.6
Accounts payable
61.4
56.6
Accrued expenses and other liabilities
7.5
(
9.5
)
Net cash provided by (used for) operating activities
12.9
(
30.6
)
Cash Flows from Investing Activities:
Capital expenditures
(
10.8
)
(
12.2
)
Proceeds from sale of fixed assets
0.1
0.2
Purchase of assets
(
12.9
)
—
Net cash used for investing activities
(
23.6
)
(
12.0
)
Cash Flows from Financing Activities:
Payments on revolving credit facility
(
15.0
)
—
Proceeds from revolving credit facility
17.9
14.0
Proceeds from other debt - net
3.3
29.1
Other financing activities
(
3.0
)
(
2.9
)
Net cash provided by financing activities
3.2
40.2
Effect of exchange rate changes on cash and cash equivalents
0.9
(
0.5
)
Net decrease in cash and cash equivalents
(
6.6
)
(
2.9
)
Cash and cash equivalents at beginning of period
48.0
34.4
Cash and cash equivalents at end of period
$
41.4
$
31.5
Supplemental Cash Flow Information
Interest paid
$
1.5
$
2.1
Income taxes paid
2.4
1.8
Operating right-of-use assets obtained
11.0
2.9
Finance right-of-use assets obtained
0.6
1.4
The accompanying notes are an integral part to these Condensed Consolidated Financial Statements.
5
THE MANITOWOC COMPANY, INC.
Condensed Consolidated Statements of Equity
For the three months ended March 31, 2025 and 2024
(Unaudited)
(In millions)
March 31,
2025
March 31,
2024
Common Stock - Par Value
Balance at beginning of period
$
0.4
$
0.4
Balance at end of period
$
0.4
$
0.4
Additional Paid-in Capital
Balance at beginning of period
$
615.1
$
613.1
Stock compensation plans
(
6.4
)
(
8.3
)
Stock-based compensation expense
2.6
3.7
Balance at end of period
$
611.3
$
608.5
Accumulated Other Comprehensive Loss
Balance at beginning of period
$
(
107.6
)
$
(
86.4
)
Other comprehensive income (loss)
17.9
(
12.5
)
Balance at end of period
$
(
89.7
)
$
(
98.9
)
Retained Earnings
Balance at beginning of period
$
199.3
$
143.5
Net income (loss)
(
6.3
)
4.5
Balance at end of period
$
193.0
$
148.0
Treasury Stock
Balance at beginning of period
$
(
67.1
)
$
(
67.3
)
Stock compensation plans
3.7
5.3
Balance at end of period
$
(
63.4
)
$
(
62.0
)
Total stockholders' equity
$
651.6
$
596.0
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
6
THE MANITOWOC COMPANY, INC.
Notes to Unaudited Condensed Consolidated Financial Statements
For the three months ended March 31, 2025 and 2024
1. Company and Basis of Presentation
The Manitowoc Company, Inc. (“Manitowoc” or the “Company”)
was founded in 1902 and has over a
120-year
tradition of providing high-quality, customer-focused products and support services to its markets. Headquartered in Milwaukee, Wisconsin, United States, Manitowoc is one of the world's leading providers of engineered lifting products and services. Manitowoc, through its wholly-owned subsidiaries, designs, manufactures, markets, distributes, and supports comprehensive product lines of mobile hydraulic cranes, lattice-boom crawler cranes, boom trucks, and tower cranes under the Aspen Equipment, Grove, Manitowoc, MGX Equipment Services, National Crane, Potain, and Shuttlelift brand names.
The Company serves a wide variety of customers, including dealers, rental companies, contractors, and government entities, across the petrochemical, industrial, commercial construction, power and utilities, infrastructure, and residential construction end markets. Due to the ongoing and predictable maintenance needed by cranes, as well as the high cost of crane downtime, Manitowoc’s aftermarket support operations provide the Company with a consistent stream of recurring revenue.
The Company has
three
reportable segments, the Americas segment, the Europe and Africa ("EURAF") segment, and the Middle East and Asia Pacific (“MEAP”) segment. The Americas segment includes the North America and South America continents. The EURAF reporting segment includes the Europe and Africa continents, excluding the Middle East region. The MEAP reporting segment includes the Asia and Australia continents and the Middle East region. The segments were identified using the “management approach,” which designates the internal organization that is used by management for making operating decisions and assessing performance. Refer to Note 17, “Segments,” for additional information.
In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments necessary for a fair statement of the results of operations for the three months ended March 31, 2025 and 2024, the cash flows for the same three-month periods, and the financial position as of March 31, 2025 and December 31, 2024, and except as otherwise discussed, such adjustments consist of only those of a normal recurring nature. The balance sheet as of December 31, 2024, was derived from the audited annual financial statements. The interim results are not necessarily indicative of results for a full year and do not contain information included in the Company’s annual consolidated financial statements and notes for the year ended December 31, 2024. Certain information and footnote disclosures, normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), have been condensed or omitted pursuant to Securities and Exchange Commission rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these financial statements be read in conjunction with the financial statements and the notes thereto included in the Company’s latest annual report on Form 10-K.
All amounts, except per share data and share amounts, are in millions throughout the tables in these notes unless otherwise indicated.
2. Recent Accounting Changes and Pronouncements
In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures”. The amendments in this ASU enhance the transparency and decision usefulness of income tax disclosures. The standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The adoption of this ASU will not have a material impact on the Company’s consolidated financial statements.
In November 2024, the FASB issued ASU No. 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expense". The amendments in this ASU require public companies to disclose more information about their expenses in their financial statements. The standard is effective for annual periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027
. Early adoption is permitted. The Company is evaluating the impact the adoption of this ASU will have on its consolidated financial statements.
7
3. A
cquisition of Assets
Effective February 4, 2025, the Company acquired certain assets and distribution rights in Georgia, North Carolina, and South Carolina from Ring Power Corporation for total cash consideration of $
12.9
million. The acquisition did not meet the definition of a business under
Accounting Standards Codification (“ASC") 805, “Business Combinations,” and has therefore been accounted for as an asset acquisition.
The purchase price was allocated to the underlying assets acquired based upon their estimated fair value at the date of the acquisition as follows:
Inventory
$
7.2
Intangible assets
2.0
Property, plant, and equipment
3.7
Total Consideration
$
12.9
8
4. Net Sales
The Company defers revenue when cash payments are received in advance of satisfying the related performance obligation. These amounts are recorded as customer advances in the Condensed Consolidated Balance Sheets.
The table below shows the change in the customer advances balance for the
three months ended March 31, 2025 and 2024.
Three Months Ended
March 31,
2025
2024
Balance at beginning of period
$
18.0
$
19.2
Cash received in advance of satisfying
performance obligations
30.3
39.1
Revenue recognized
(
23.9
)
(
37.7
)
Currency translation
0.5
(
0.3
)
Balance at end of period
$
24.9
$
20.3
The Company recognizes a contract asset for certain remanufacturing, repair, and field service work when service is completed but unbilled as of the end of the period. Contract assets are recorded in other current assets in the Condensed Consolidated Balance Sheets. Contract assets were $
8.2
million and $
8.8
million as of March 31, 2025 and December 31, 2024, respectively.
5. Fair Value of Financial Instruments
The following table sets forth the
Company’s financial assets and liabilities related to foreign currency exchange contracts ("FX Forward Contracts") and The Manitowoc Company, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan") that were accounted for at fair value as of March 31, 2025 and December 31, 2024.
Fair Value as of March 31, 2025
Level 1
Level 2
Level 3
Total
Recognized Location
Current Assets:
FX Forward Contracts
$
—
$
0.9
$
—
$
0.9
Other current assets
Deferred Compensation Plan - Program B
8.6
—
—
8.6
Other non-current assets
Total current assets at fair value
$
8.6
$
0.9
$
—
$
9.5
Current Liabilities:
FX Forward Contracts
$
—
$
0.1
$
—
$
0.1
Accounts payable and
accrued expenses
Fair Value as of December 31, 2024
Level 1
Level 2
Level 3
Total
Recognized Location
Current Assets:
FX Forward Contracts
$
—
$
0.1
$
—
$
0.1
Other current assets
Deferred Compensation Plan - Program B
8.8
—
—
8.8
Other non-current assets
Total current assets at fair value
$
8.8
$
0.1
$
—
$
8.9
Current Liabilities:
FX Forward Contracts
$
—
$
3.4
$
—
$
3.4
Accounts payable and
accrued expenses
The fair value of the $
300.0
million se
nior secured second lien notes due on
October 1, 2031
, with an annual coupon rate of
9.25
% (the “2031 Notes”), was $
308.8
m
illion as of March 31, 2025. Refer to Note 11, “Debt,” for a description of the 2031 Notes and the related carrying value.
The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company estimates the fair value of its 2031 Notes based on quoted market prices of the instruments; because these markets are typically actively traded, the liabilities are classified as Level 1 within the valuation hierarchy. The carrying values of cash and cash
9
equivalents, accounts receivable, accounts payable, and short-term variable debt, including any amounts outstanding under the Company's revolving credit facility, approximate fair value, without being discounted as of March 31, 2025, due to the short-term nature of these instruments.
FX Forward Contracts are valued through an independent valuation source which uses an industry standard data provider, with resulting valuations periodically validated through third-party or counterparty quotes. As such, these derivative instruments are classified within Level 2. Refer to Note 6, “Derivative Financial Instruments,” for additional information.
The Deferred Compensation Plan utilizes a rabbi trust to hold assets intended to satisfy the Company’s
corresponding future benefit obligations. The plan assets and corresponding obligations for Program B under the Deferred Compensation Plan are classified within Level 1.
6. Derivative Financial Instruments
The Company’s risk management objective is to ensure that business exposures to risks are minimized using the most effective and efficient methods to eliminate, reduce, or transfer such exposures. Operating decisions consider these associated risks and, whenever possible, transactions are structured to avoid or mitigate these risks.
From time to time, the Company enters into FX Forward Contracts to manage the exposure on forecasted transactions denominated in non-functional currencies and to manage the risk of transaction gains and losses associated with assets/liabilities in currencies other than the functional currency of certain subsidiaries. Certain of these FX Forward Contracts are designated as cash flow hedges. To the extent these derivatives are effective in offsetting the variability of the hedged cash flows, changes in the derivatives’ fair value are not included in current earnings but are included in accumulated other comprehensive income (loss) ("AOCI"). These changes in fair value are reclassified into earnings as a component of cost of sales, as applicable, when the forecasted transaction impacts earnings. In addition, if the forecasted transaction is no longer probable, the cumulative change in the derivatives’ fair value is recorded as a component of other income (expense) – net in the period in which the transaction is no longer considered probable of occurring. No amounts were recorded related to forecasted transactions no longer being probable during the three months ended March 31, 2025 and 2024.
The Company had FX Forward Contracts with aggregate notional amounts
of $
73.7
million and $
129.7
milli
on in U.S. dollar equivalent as of March 31, 2025 and December 31, 2024, respectively. The FX Forward Contracts purchased are denominated in various foreign currencies. The aggregate notional amount outstanding as of March 31, 2025, is scheduled to mature within
one
year
. Net unrealize
d gains (losses), net of income tax, recorded in AOC
I for FX Forward Contracts were $
0.8
million and ($
1.7
) million
as of March 31, 2025 and December 31, 2024, respectively.
The ne
t gains (losses) recorded in the Condensed Consolidated Statements of Operations for FX Forward Contracts for the three months ended March 31, 2025 and 2024 are summarized as follows:
Three Months Ended
March 31,
Recognized Location
2025
2024
Designated
Cost of sales
$
(
0.6
)
$
(
0.9
)
Non-Designated
Other income (expense) - net
$
1.3
$
1.4
7. Inventories
The components of inventories as of
March 31, 2025 and December 31, 2024 are summarized as follows:
March 31,
2025
December 31,
2024
Raw materials
$
164.8
$
121.4
Work-in-process
159.8
114.8
Finished goods
377.1
373.2
Total Inventories
$
701.7
$
609.4
10
8. Property, Plant, and Equipment
The components of property, plant, and equipment as of
March 31, 2025 and December 31, 2024 are summarized as follows:
March 31,
2025
December 31,
2024
Land
$
14.7
$
14.3
Building and improvements
207.2
203.3
Machinery, equipment, and tooling
328.4
318.3
Furniture and fixtures
13.6
13.3
Computer hardware and software
130.8
129.6
Rental cranes
185.0
185.7
Construction in progress
7.6
6.9
Total cost
887.3
871.4
Less: accumulated depreciation
(
542.9
)
(
525.2
)
Property, plant, and equipment - net
$
344.4
$
346.2
Property, plant, and equipment is depreciated over the estimated useful life of the asset using the straight-line depreciation method for financial reporting and accelerated methods for income tax purposes.
Additions to property, plant, and equipment included in accounts payable and accrued expenses in the Condensed Consolidated Balance Sheets as of March 31, 2025 and Dec
ember 31, 2024 were $
1.5
million and $
5.3
millio
n, respectively.
9. Goodwill and Intangible Assets
The changes in the carrying amount of goodwill for the three months ended
March 31, 2025 are summarized as follows:
Americas - Distribution
MEAP
Consolidated
Balance as of December 31, 2024
$
14.4
$
63.4
$
77.8
Foreign currency impact
—
0.2
0.2
Balance as of March 31, 2025
$
14.4
$
63.6
$
78.0
The gross carrying amount, accumulated impairment and net book value of the Company's goodwill balances by reportable segment as of
March 31, 2025 and December 31, 2024, are summarized as follows:
March 31, 2025
December 31, 2024
Gross Carrying Amount
Accumulated Impairment Amount
Net Book Value
Gross Carrying Amount
Accumulated Impairment Amount
Net Book Value
Americas
$
180.9
$
(
166.5
)
$
14.4
$
180.9
$
(
166.5
)
$
14.4
EURAF
82.2
(
82.2
)
—
82.2
(
82.2
)
—
MEAP
63.6
—
63.6
63.4
—
63.4
Total
$
326.7
$
(
248.7
)
$
78.0
$
326.5
$
(
248.7
)
$
77.8
The Company performs its annual goodwill impairment test during the fourth quarter, or more frequently if events or changes in circumstances indicate that there might be an impairment of the assets. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. The Company determined there was no triggering event for the three months ended March 31, 2025.
11
The gross carrying amount, accumulated amortization, and net book value of the Company’s intangible assets other than goodwill as of
March 31, 2025 and December 31, 2024, are summarized as follows:
March 31, 2025
December 31, 2024
Gross
Carrying
Amount
Accumulated
Amortization
Amount
Net
Book
Value
Gross
Carrying
Amount
Accumulated
Amortization
Amount
Net
Book
Value
Definite lived intangible assets:
Customer relationships
$
28.3
$
(
13.5
)
$
14.8
$
26.3
$
(
13.0
)
$
13.3
Patents
28.8
(
28.5
)
0.3
28.1
(
27.8
)
0.3
Noncompetition agreements
4.2
(
3.0
)
1.2
4.2
(
2.8
)
1.4
Trademarks and tradenames
2.2
(
1.6
)
0.6
2.2
(
1.5
)
0.7
Total
$
63.5
$
(
46.6
)
$
16.9
$
61.5
$
(
45.8
)
$
15.7
Indefinite-lived intangible assets:
Trademarks and tradenames
$
91.4
$
—
$
91.4
$
89.2
$
—
$
89.2
Distribution network
14.1
—
14.1
13.6
—
13.6
Total
105.5
—
105.5
102.8
—
102.8
Total intangible assets
$
169.0
$
(
46.6
)
$
122.4
$
164.3
$
(
45.8
)
$
118.5
The Company performs its annual indefinite-lived intangible assets impairment testing during the fourth quarter, or more frequently if events or changes in circumstances indicate that there might be an impairment of the asset. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. The Company determined there was no triggering event for the three months ended March 31, 2025.
Definite lived intangible assets and long-lived assets are subject to impairment testing whenever events or circumstances indicate that the carrying value of the assets may not be recoverable. The Company determined there was no triggering event for the three months ended March 31, 2025.
Other intangible assets with definite lives are amortized over their estimated useful lives. Amortization expense for the three months ended March 31, 2025 and 2024 was $
0.8
million and $
0.7
million, respectively.
10. Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses as of
March 31, 2025 and December 31, 2024 are summarized as follows:
March 31, 2025
December 31, 2024
Trade accounts payable
$
268.4
$
205.5
Employee-related expenses
44.7
43.2
Accrued vacation
25.5
23.3
Miscellaneous accrued expenses
117.4
117.4
Total accounts payable and accrued expenses
$
456.0
$
389.4
11. Debt
Outstanding debt as of
March 31, 2025 and December 31, 2024 is summarized as follows:
March 31, 2025
December 31, 2024
Borrowings under senior secured asset-based
revolving credit facility
$
83.3
$
79.0
Senior secured second lien notes due 2031
300.0
300.0
Other debt
20.7
16.4
Deferred financing costs
(
5.0
)
(
5.2
)
Total debt
399.0
390.2
Short-term borrowings and current portion of long-term
debt
(
17.6
)
(
13.1
)
Long-term debt
$
381.4
$
377.1
12
On March 25, 2019, the Company and certain subsidiaries of the Company (the “Loan Parties”) entered into a credit agreement (the “ABL Credit Agreement”) with JP Morgan Chase Bank, N.A. as administrative and collateral agent, and certain financial institutions party thereto as lenders, providing for a senior secured asset-based revolving credit facility (the “ABL Revolving Credit Facility”) of up to $
275.0
million. The borrowing capacity under the ABL Revolving Credit Facility is based on the value of inventory, accounts receivable and certain fixed assets of the Loan Parties. The Loan Parties’ obligations under the ABL Revolving Credit Facility are secured on a first-priority basis, subject to certain exceptions and permitted liens, by substantially all of the personal property and fee-owned real property of the Loan Parties. The liens securing the ABL Revolving Credit Facility are senior in priority to the second-priority liens securing the obligations under the 2031 Notes and the related guarantees. The ABL Revolving Credit Facility includes a $
75.0
million letter of credit sub-facility, $
10.0
million of which is available to the Company’s German subsidiary that is a borrower under the ABL Revolving Credit Facility (the “German Borrower”).
On June 17, 2021, the Company amended the ABL Credit Agreement to adjust certain negative covenants which reduced restrictions on the Company’s ability to expand its rental business. On May 19, 2022, the Company further amended the ABL Credit Agreement to (i) extend the maturity date to May 19, 2027 (subject to a springing maturity date of December 30, 2025 if our senior secured lien notes due April 1, 2026 have not been repaid in full or refinanced prior to December 30, 2025), (ii) permit the inclusion, subject to certain limitations, of the crane rental assets of certain subsidiaries in the borrowing base used to calculate availability under the ABL Credit Agreement, (iii) permit separate financing of crane rental assets not included in the borrowing base and (iv) replace U.S. dollar London Inter-bank Offered Rate with interest rates based on the secured overnight financing rate plus a credit spread adjustment (“SOFR”).
On September 18, 2024, the Company further amended the ABL Credit Agreement to (i) increase the aggregate commitment by $
50.0
million to a total aggregate commitment of up to $
325.0
million, of which $
100.0
million is available to the German Borrower, (ii) increase the swingline sublimit by $
20.0
million to an aggregate $
50.0
million, of which $
20.0
million is available to the German Borrower, and (iii) extend the maturity date to September 18, 2029.
Borrowings under the ABL Revolving Credit Facility bear interest at a variable rate using either the Alternate Base Rate or Term Benchmark, Applicable Overnight Rate, Central Bank Rate ("CBR") or RFR rate (each as defined in the ABL Credit Agreement) plus the applicable spread set forth below. The variable interest rate is based upon the average availability as of the most recent determination date as follows:
Average quarterly availability
Alternative base rate spread
SOFR spread
Category 1
≥ 66% of Aggregate Commitment
0.25
%
1.25
%
Category 2
< 66% but ≥ 33% of Aggregate Commitment
0.50
%
1.50
%
Category 3
< 33% of Aggregate Commitment
0.75
%
1.75
%
As of March 31, 2025 and December 31, 2024, the Company had
$
83.3
million and
$
79.0
million
, respectively, of borrowings outstanding under the ABL Revolving Credit Facility. During the period from September 18, 2024 to March 31, 2025, the spreads for Term Benchmark, Applicable Overnight Rate, CBR and RFR spread and Alternative Base Rate borrowings are deemed to be in Category 2 as defined in the amended ABL Credit Agreement. Excess availability as of March 31, 2025 was $
238.3
million, which represents
available revolver borrowing capacity of $
325.0
million less
$
83.3
million of borrowings outstanding and $
3.4
million of U.S. letters of credit outstanding.
As of March 31, 2025, the Company had $
20.7
million of other indebtedness outstanding that has a weighted-average interes
t rate of
4.2
%. This debt includes balances on local credit lines, overdraft facilities, and other financing arrangements.
On September 19, 2024, the Company and certain of its subsidiaries entered into an indenture with U.S. Bank Trust Company, National Association as trustee and notes collateral agent, pursuant to which the Company issued $
300.0
million aggregate principal amount of the 2031 Notes with an annual coupon rate of
9.25
%.
Interest on the 2031 Notes is payable in cash semi-annually in arrears on April 1 and October 1 of each year.
The
2031 Notes are fully and unconditionally guaranteed on a senior secured second lien basis, jointly and severally, by each of the Company’s existing and future domestic subsidiaries that is either a guarantor or a borrower under the ABL Revolving Credit Facility or that guarantees certain other debt of the Company or a guarantor. The 2031 Notes and the related guarantees are secured on a second-priority basis, subject to certain exceptions
13
and
permitted liens, by pledges of capital stock and other equity interests and other security interests in substantially all of the personal property and fee-owned real property of the Company and of the guarantors that secure obligations under the ABL Revolving Credit Facility. The Company used the net proceeds from this offering, together with cash on hand, to redeem all of its outstanding
9.00
% senior secured second lien notes due 2026.
Both the ABL Revolving Credit Facility and the 2031 Notes include customary covenants which include, without limitation, restrictions on the Company’s ability and the ability of the Company’s restricted subsidiaries to incur, assume or guarantee additional debt or issue certain preferred shares, pay dividends on or make other distributions in respect of the Company’s capital stock or make other restricted payments, make certain investments, sell or transfer certain assets, create liens on certain assets to secure debt, consolidate, merge, sell, or otherwise dispose of all or substantially all of the Company’s assets, enter into certain transactions with affiliates and designate the Company’s subsidiaries as unrestricted. Both the ABL Revolving Credit Facility and the 2031 Notes also include customary events of default. The ABL Revolving Credit Facility has customary representations and warranties including, as a condition to borrowing, that all such representations and warranties are true and correct, in all material respects, on the date of the borrowing, including representations as to no material adverse change in the Company’s business or financial condition since December 31, 2021.
Additionally, the ABL Revolving Credit Facility contains a covenant requiring the Company to maintain a minimum fixed charge coverage ratio under certain circumstances set forth in the ABL Credit Agreement.
As of March 31, 2025
, the Company was in compliance with all affirmative and negative covenants in its debt instruments, inclusive of the financial covenants pertaining to the ABL Revolving Credit Facility and 2031 Notes. Based upon management’s current plans and outlook, the Company believes it will be able to comply with these covenants during the subsequent
twelve months
.
12. Accounts Receivable Factoring
The Company has two non-U.S. accounts receivable financing programs with
no
maximum availability. Transactions under the non-U.S. programs were accounted for as sales in accordance with
ASC Topic 860, “Transfers and Servicing.” Under these financing programs, the Company has the ability to sell eligible receivables up to the customer's maximum limit.
For the three months ended March 31, 2025 and 2024
, cash proceeds from the factoring of accounts receivable qualifying as sales were $
52.6
and $
36.0
million, respectively.
Financing charges incurred from the factoring of accounts receivable qualifying as sales for the three months ended March 31, 2025 and 2024
were immaterial.
13. Income Taxes
The Company’s income (loss) before income taxes includes amounts from both U.S. and foreign jurisdictions. The annual effective tax rate varies from the U.S. federal statutory rate of 21% due to results of foreign operations that are subject to income taxes at different statutory rates. In addition, tax expense is impacted by losses in jurisdictions where no tax benefit can be realized.
For the three months ended March 31, 2025 and 2024, the Company recorded a benefit for income taxes of $
2.5
million and a provision for income taxes of $
1.9
million, respectively.
As of March 31, 2025 and December 31, 2024
, the Company’s unrecognized tax benefits, excluding interest and penalties, were $
14.0
million and $
13.9
million, respectively.
14. Net Income (Loss) Per Common Share
The following is a reconciliation of the weighted average shares outstanding used to compute basic and
diluted net income (loss) per common share:
Three Months Ended
March 31,
2025
2024
Basic weighted average common shares outstanding
35,273,783
35,265,449
Effect of dilutive securities - equity
compensation awards
—
795,191
Diluted weighted average common shares outstanding
35,273,783
36,060,640
14
Equity compensation awards for which total employee proceeds from exercise exceed the average fair value of the same equity incentive instrument over the period have an anti-dilutive effect on earnings per share during periods with net income, and accordingly, are excluded from diluted weighted average common shares outstanding. Due to the net loss incurred during the three months ended March 31, 2025, the assumed exercise of all equity instruments was anti-dilutive and, therefore, not included in the net diluted income (loss) per share calculations for the period.
Anti-dilutive equity instruments of
497,801
common shares were excluded from the computation of diluted net earnings per share for the three months ended March 31,
2024.
No
cash dividends were declared or paid during the
three months ended March 31, 2025 and 2024
.
15. Equity
Authorized capital consists of
75.0
million shares of $
0.01
par value common stock and
3.5
million shares of $
0.01
par value preferred stock.
None
of the preferred shares have been issued.
As of March 31, 2025, the Company ha
s $
29.3
million remaining under the authorization from the Board of Directors to purchase up to $
35.0
million of the Company’s
common stock at management’s discretion.
A reconciliation of the changes in accumulated other comprehensiv
e income (loss), net of income tax, by component for the three months ended March 31, 2025 and 2024 are summarized as follows:
Cash Flow Hedges
Pension &
Postretirement
Foreign Currency
Translation
Total
Balance as of December 31, 2023
$
1.3
$
(
10.3
)
$
(
77.4
)
$
(
86.4
)
Other comprehensive loss before
reclassifications
(
2.5
)
—
(
11.0
)
(
13.5
)
Amounts reclassified from accumulated other
comprehensive income (loss)
0.9
0.1
—
1.0
Net other comprehensive income (loss)
(
1.6
)
0.1
(
11.0
)
(
12.5
)
Balance as of March 31, 2024
$
(
0.3
)
$
(
10.2
)
$
(
88.4
)
$
(
98.9
)
Balance as of December 31, 2024
$
(
1.7
)
$
(
7.7
)
$
(
98.2
)
$
(
107.6
)
Other comprehensive income (loss) before
reclassifications
2.0
(
0.4
)
15.8
17.4
Amounts reclassified from accumulated other
comprehensive income (loss)
0.5
—
—
0.5
Net other comprehensive income (loss)
2.5
(
0.4
)
15.8
17.9
Balance as of March 31, 2025
$
0.8
$
(
8.1
)
$
(
82.4
)
$
(
89.7
)
15
A reconciliation of the reclassifications out of accumulated other comprehensive loss, net of income taxes
for the three months ended March 31, 2025 and 2024 are summarized as follows:
Amount Reclassified from Accumulated Other Comprehensive Loss
Three Months Ended March 31,
2025
Three Months Ended March 31,
2024
Recognized
Location
Gains (losses) on cash flow hedges
FX Forward Contracts
$
(
0.6
)
$
(
0.9
)
Cost of sales
Total before income taxes
(
0.6
)
(
0.9
)
Benefit for income taxes
0.1
—
Total, net of income taxes
$
(
0.5
)
$
(
0.9
)
Amortization of pension and
postretirement items
Actuarial losses
$
—
$
(
0.1
)
(a)
Other income (expense) - net
Amortization of prior service cost
—
—
(a)
Other income (expense) - net
Total before income taxes
—
(
0.1
)
Provision for income taxes
—
—
Total, net of income taxes
$
—
$
(
0.1
)
Total reclassifications for the period,
net of income taxes
$
(
0.5
)
$
(
1.0
)
(a) These accumulated other comprehensive
income (loss) components are components of net periodic pension cost (refer to Note 20, “Employee Benefit Plans,” for further details)
16. Stock-Based Compensation
Equity compensation awards may be granted to certain eligible employees or non-employee directors. A detailed description of the awards granted prior to 2025 is included in the Company’s 2024 Annual Report on Form 10-K.
During the three months ended March 31, 2025, the Company modified certain 2023 and 2024 restricted stock units and performance share units to settle them in cash in lieu of stock. The performance conditions, if applicable, and vesting schedules remain unchanged for these awards.
Total stock-based compensation expense, including cash-settled liability awards, was $
2.6
million
for the three months ended March 31, 2025
and $
3.7
million for the three months ended March 31,
2024. The Company reports stock-based compensation expense within engineering, selling, and administrative expenses in the Condensed Consolidated Statements of Operations. The Company recognizes stock-based compensation expense over the award’s vesting period, subject to the retirement, death, or disability provisions of the 2013 Omnibus Incentive Plan.
The Company granted
no
restricted stock units and performance share units to employees or non-employee directors during the three months ended March 31, 2025.
17. Segments
The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the
President & CEO
, who is also the Company’s Chief Operating Decision Maker (“CODM”), for making decisions about the allocation of resources and assessing performance as the source of the Company’s reportable operating segments.
The Company has
three
reportable segments: Americas, EURAF, and MEAP.
The Americas reporting segment includes the North America and South America continents. The EURAF reporting segment includes the Europe and Africa continents, excluding the Middle East region. The MEAP reporting segment includes the Asia and Australia continents and the Middle East region.
16
The CODM evaluates the performance of its reportable segments based on net sales and operating income. Segment net sales are recognized in the geographic region the product is sold. Each reportable segment has new and non-new machine sales. Operating income for each segment includes net sales to third parties, cost of sales directly attributable to the segment, selling and administrative costs directly attributable to the segment, and engineering costs directly attributable to the segment. Manufacturing variances generated by the manufacturing locations within each operating segment are maintained in each segment’s operating income. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as stock-based compensation expenses, income taxes and other separately managed general, and administrative costs. The Company does not include intercompany sales between segments for management reporting purposes. The CODM does not evaluate performance of the reportable segments based on total assets.
The following table shows information by reportable segment for the
three months ended March 31, 2025 and 2024:
Three Months Ended March 31, 2025
Three Months Ended March 31, 2024
Americas
EURAF
MEAP
Total
Americas
EURAF
MEAP
Total
Revenues from external customers
$
259.3
$
145.6
$
66.0
$
470.9
$
283.2
$
143.0
$
68.9
$
495.1
Less: (a)
Cost of sales
208.3
124.1
48.7
381.1
222.8
124.6
55.2
402.6
Engineering, selling, and administration costs
32.4
32.2
5.9
70.5
29.9
30.1
5.3
65.3
Other segment items (b)
0.9
0.6
—
1.5
1.0
0.1
0.2
1.3
Segment operating income (loss)
17.7
(
11.3
)
11.4
17.8
29.5
(
11.8
)
8.2
25.9
Reconciliation of segment operating income (loss)
Interest expense
(
8.7
)
(
9.2
)
Amortization of deferred financing fees
(
0.4
)
(
0.3
)
Other (income) expense - net
(
5.0
)
0.7
Unallocated amounts:
Other corporate expenses
(
12.5
)
(
10.7
)
Income (loss) before income taxes
$
(
8.8
)
$
6.4
Other Segment Disclosures
Depreciation and amortization (c)
8.8
5.3
0.7
14.8
7.9
5.9
0.8
14.6
Capital expenditures
5.8
3.6
1.0
10.4
4.2
7.2
0.8
12.2
(a)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(b)
Other segment items for each reportable segment includes:
Americas — amortization expense and restructuring expense.
EURAF — restructuring expense.
MEAP — restructuring expense.
(c)
The amount of depreciation and amortization disclosed by reportable segment are included within cost of sales or engineering, selling, and administration costs, as applicable.
Net sales by geographic area for the
three months ended March 31, 2025 and 2024 are summarized as follows:
Three Months Ended
March 31,
2025
2024
United States
$
241.2
$
249.2
Europe
141.5
138.2
Other
88.2
107.7
Total net sales
$
470.9
$
495.1
New machine and non-new machine sales for the
three months ended March 31, 2025 and 2024 are summarized as follows:
Three Months Ended
March 31,
2025
2024
New machine sales
$
310.3
$
349.9
Non-new machine sales
160.6
145.2
Total net sales
$
470.9
$
495.1
17
18. Commitments and Contingencies
The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business which have not been fully resolved. The outcome of any litigation is inherently uncertain. When a loss related to a legal proceeding or claim is probable and reasonably estimable, the Company accrues its best estimate for the ultimate resolution of the matter.
As of March 31, 2025
, various product-related lawsuits were pending. To the extent permitted under applicable law, all of these lawsuits are insured with self-insurance retention levels. The Company’s self-insurance retention levels have varied over the last
10 years
. As of
March 31, 2025, the largest self-insured retention level for new occurrences currently maintained by the Company is
$
3.0
million per occurrence and applies to product liability claims arising in North America.
As of March 31, 2025, current and long-term product liability reserves were $
1.8
million and $
5.6
million, respectively. As of December 31, 2024, current and long-term product liability reserves were $
1.4
million and $
5.0
million, respectively.
Current product liability reserves are included within other liabilities and long-term product liability reserves are included within other non-current liabilities in the Condensed Consolidated Balance Sheets. These amounts are not reduced for insurance recoveries for claims above the Company's self-insured retention level. As of March 31, 2025 and December 31, 2024
, the Company had
zero
estimated insurance recoveries included in other current assets in the Condensed Cons
olidated Balance Sheets.
Reserves for product-related lawsuits were estimated using a combination of actual case reserves and actuarial methods. Based on the Company’s experience in defending product liability claims, management believes the reserves are adequate for estimated case resolutions on aggregate self-insured claims and insured claims. Any recoveries from insurance carriers are dependent upon the legal sufficiency of claims and solvency of insurance carriers.
As of March 31, 2025 and December 31, 2024, the Company had reserves of
$
45.6
million and
$
45.3
million, respectively, for warranty and other related claims included in product warranties and other non-current liabilities in the Condensed Consolidated Balance Sheets. Certain of these warranty and other related claims involve matters in dispute that ultimately are resolved by negotiation, arbitration, or litigation. Refer to Note 19, “Guarantees,” for further information.
It is reasonably possible that the estimates for warranty and other related claims, product liability, asbestos-related claims, and other various legal matters may change based upon new information that may arise or matters that are beyond the scope of the Company’s historical experience. Presently, there are no reliable methods to estimate the amount of any such potential changes. The ultimate resolution of these matters, individually and in the aggregate, is not expected to have a material adverse effect on the Company’s financial condition, results of operations or cash flows.
In July 2017, the Company received an Information Request from the United States Environmental Protection Agency (“U.S. EPA”) relating to the sales of cranes manufactured between January 1, 2014 and July 31, 2017 and the Company’s related participation in the Transition Program for Equipment Manufacturers (the “TPEM” program). The TPEM program allowed equipment manufacturers to delay installing engines meeting Tier 4 final emission standards in their products, subject to certain percentage allowance restrictions.
As of March 31, 2025, the Company agreed to the terms of a Consent Decree with the U.S. EPA and the U.S. Department of Justice regarding alleged violations of the TPEM program. The Consent Decree was entered by the federal district court for the Eastern District of Wisconsin and provides that the Company pay a civil penalty of $
42.6
million, excluding accrued interest from the date of the Consent Decree, and complete an emissions mitigation project upgrading a short-line locomotive engine in Maryland. Completion of the terms in the Consent Decree will settle this matter and release the Company from civil claims under the Clean Air Act related to the Company’s participation in the TPEM program.
The total recorded liability in accounts payable and accrued expenses in the Company’s Condensed Consolidated Balance Sheets was $
45.0
million as of March 31, 2025, which accounts for the civil penalty and emissions mitigation project.
On April 25, 2025, the Company paid the civil penalty amounting to $
43.2
million, which includes $
0.6
million of accrued interest from the date of the Consent Decree.
19. Guarantees
The Company periodically enters into transactions with customers that provide for buyback commitments. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise the buyback option. If it is determined that the customer has a significant economic incentive to exercise that right, the revenue is deferred, and the agreement is accounted for as a lease in accordance with ASC Topic 842 – “Leases” (“Topic 842”). If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the product is transferred to the customer. The revenue deferred related to buyback obligations accounted for under Topic
18
842 included in other current and non-current liabilities as of March 31, 2025 and December 31, 2024 was $
14.6
million and $
14.9
million, respectively. The total amount of buyback commitments given by the Company and outstanding as of March 31, 2025 and December 31, 2024
was $
24.8
million and $
29.9
million, respectively. These amounts are not reduced for amounts the Company would recover from the repossession and subsequent resale of the cranes. The buyback commitments expire at various times through 2031. The Company also has various loss guarantees with maximum liabilities of $
24.7
milli
on and $
14.3
million as of
March 31, 2025 and December 31, 2024, respectively. These amounts are not reduced for amounts the Company would recover from the repossession and subsequent resale of the cranes securing the related guarantees.
In the normal course of business, the Company provides its customers a warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranties generally provide that products will be free from defects for periods ranging from
12 months
to
60 months
. In addition, the Company may incur other warranty related costs outside of its standard warranty period. Costs for other warranty-related work are recorded in the period a loss is probable and can be reasonably estimated.
Below is a table summarizing the warranty and other warranty related work for the
three months ended March 31, 2025 and 2024.
Three Months Ended
March 31,
2025
2024
Balance at beginning of period
$
45.3
$
56.8
Adjustments to accruals for warranties
6.0
5.3
Settlements made (in cash or in kind) during
the period
(
6.5
)
(
8.8
)
Currency translation
0.8
(
0.7
)
Balance at end of period
$
45.6
$
52.6
The long-term portion of the warranty liability is recorded in other non-current liabilities in the Condensed Consolidated Balance Sheets.
The Company sells extended warranty contracts, which it accounts for as a service type warranty under ASC Topic 606 – “Revenue from Contracts with Customers.” Revenue associated with extended warranty contracts is deferred and amortized on a straight-line basis over the duration of the extended warranty period. As of March 31, 2025 and December 31, 2024 there was
$
9.2
million and $
8.6
million
, respectively, of deferred revenue included in other current and non-current liabilities in the Condensed Consolidated Balance Sheets.
20. Employee Benefit Plans
The Company provides certain pension, health care, and death benefits to eligible retirees and their dependents. The funding mechanism for such benefits varies based on the country where the plan is located and the related plan. Eligibility for pension coverage is based on retirement qualifications. Healthcare benefits may be subject to deductibles, co-payments, and other limitations. The Company reserves the right to modify benefits unless prohibited by local laws or regulations.
The components of net periodic benefit cost (income) for the
three months ended March 31, 2025 and 2024 are summarized as follows:
Three Months Ended March 31, 2025
Postretirement
U.S.
Non-U.S.
Health and
Pension
Pension
Other
Plan
Plans
Plans
Service cost - benefits earned during the period
$
—
$
0.3
$
—
Interest cost of projected benefit obligations
1.3
0.6
0.1
Expected return on plan assets
(
1.1
)
(
0.4
)
—
Amortization of prior service cost
—
—
—
Amortization of actuarial net loss
0.3
0.1
(
0.4
)
Net periodic benefit cost (income)
$
0.5
$
0.6
$
(
0.3
)
19
Three Months Ended March 31, 2024
Postretirement
U.S.
Non-U.S.
Health and
Pension
Pension
Other
Plan
Plans
Plans
Service cost - benefits earned during the period
$
—
$
0.3
$
—
Interest cost of projected benefit obligations
1.3
0.7
0.1
Expected return on plan assets
(
1.0
)
(
0.4
)
—
Amortization of prior service cost
—
—
—
Amortization of actuarial net (gain) loss
0.5
—
(
0.4
)
Net periodic benefit cost (income)
$
0.8
$
0.6
$
(
0.3
)
The components of net periodic benefit cost (income) other than the service cost component are included in other income (expense) - net in the Condensed Consolidated Statements of Operations.
20
Item 2. Management’s Discussion and Analysis of
Financial Condition and Results of Operations
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, including the financial statements, accompanying notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations therein, and the interim condensed consolidated financial statements and accompanying notes included in this Quarterly Report on Form 10-Q.
All dollar amounts are in millions throughout the tables included in Management’s Discussion and Analysis of Financial Condition and Results of Operations unless otherwise indicated.
Cautionary Statements Regarding Forward-Looking Information
All of the statements in this Quarterly Report on Form 10-Q, other than historical facts, are forward-looking statements, including, without limitation, the statements made in the “Management's Discussion and Analysis of Financial Condition and Results of Operations.” As a general matter, forward-looking statements are those focused upon anticipated events or trends, expectations and beliefs relating to matters that are not historical in nature. The words “could,” “should,” “may,” “feel,” “anticipate,” “aim,” “preliminary,” “expect,” “believe,” “estimate,” “intend,” “intent,” “plan,” “will,” “foresee,” “project,” “forecast,” or the negative thereof or variations thereon, and similar expressions identify forward-looking statements.
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for these forward-looking statements. In order to comply with the terms of the safe harbor, the Company notes that forward-looking statements are subject to known and unknown risks, uncertainties and other factors relating to the Company’s operations and business environment, all of which are difficult to predict and many of which are beyond the control of the Company. These known and unknown risks, uncertainties and other factors could cause actual results to differ materially from those matters expressed in, anticipated by or implied by such forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to:
•
Macroeconomic conditions, including inflation, elevated interest rates, and tariffs, as well as prior supply chain, labor and logistics constraints, have had, and may continue to have, a negative impact on Manitowoc’s ability to convert backlog into revenue which could, and has, impacted its financial condition, cash flows, and results of operations (including future uncertain impacts);
•
actions of competitors;
•
changes in economic or industry conditions generally or in the markets served by Manitowoc, including tariffs;
•
geopolitical events, including the ongoing conflicts in Ukraine and in the Middle East, tariffs, other political and economic conditions and risks and other geographic factors, has had and may continue to lead to market disruptions, including volatility in commodity prices (including oil and gas), raw material and component costs, energy prices, inflation, consumer behavior, supply chain, and credit and capital markets, and could result in the impairment of assets;
•
changes in customer demand, including changes in global demand for high-capacity lifting equipment, changes in demand for lifting equipment in emerging economies and changes in demand for used lifting equipment including changes in government approval and funding of projects;
•
the ability to convert backlog, orders, and order activity into sales and the timing of those sales;
•
adverse changes to trade policy, including export duties, tariffs, import controls and trade barriers (including quotas);
•
the ability to focus on customers, new technologies, and innovation;
•
uncertainties associated with new product introductions, the successful development and market acceptance of new and innovative products that drive growth;
•
failure to comply with regulatory requirements related to the products and aftermarket services the Company sells;
•
the ability to capitalize on key strategic opportunities and the ability to implement Manitowoc’s long-term initiatives;
•
the ability of Manitowoc's customers to receive financing;
•
risks associated with high debt leverage;
•
impairment of goodwill and/or intangible assets;
•
changes in revenues, margins and costs;
21
•
the ability to increase operational efficiencies across Manitowoc and to capitalize on those efficiencies;
•
the ability to generate cash and manage working capital consistent with Manitowoc’s stated goals;
•
work stoppages, labor negotiations, labor rates, and labor costs;
•
the Company’s ability to attract and retain qualified personnel;
•
changes in the capital and financial markets;
•
the ability to complete and appropriately integrate acquisitions, strategic alliances, joint ventures or other significant transactions;
•
issues associated with the availability and viability of suppliers;
•
the ability to significantly improve profitability;
•
realization of anticipated earnings enhancements, cost savings, strategic options and other synergies, and the anticipated timing to realize those savings, synergies and options;
•
the replacement cycle of technologically obsolete products;
•
foreign currency fluctuation and its impact on reported results;
•
risks associated with data security and technological systems and protections;
•
the ability to direct resources to those areas that will deliver the highest returns;
•
risks associated with manufacturing or design defects;
•
natural disasters, other weather events, pandemics and other public health crises disrupting commerce in one or more regions of the world;
•
issues relating to the ability to timely and effectively execute on manufacturing strategies, general efficiencies, and capacity utilization of the Company’s facilities;
•
the ability to focus and capitalize on product and service quality and reliability;
•
issues associated with the quality of materials, components and products sourced from third parties and the ability to successfully resolve those issues;
•
changes in laws throughout the world, including governmental regulations on climate change;
•
the inability to defend against potential infringement claims on intellectual property rights;
•
the ability to sell products and services through distributors and other third parties;
•
issues affecting the effective tax rate for the year;
•
acts of terrorism; and
•
other risk factors detailed in Manitowoc's 2024 Annual Report on Form 10-K, as such may be amended or supplemented in Manitowoc’s subsequently filed Quarterly Reports on 10-Q (including this report), and its other filings with the United States Securities and Exchange Commission.
These statements reflect the current views and assumptions of management with respect to future events. Except to the extent required by the federal securities laws, the Company does not undertake, and hereby disclaims, any duty to update these forward-looking statements, even though its situation and circumstances may change in the future. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this report. The inclusion of any statement in this report does not constitute an admission by the Company or any other person that the events or circumstances described in such statement are material.
Current Events
As disclosed in Part I, Item 1A: Risk Factors, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, the company’s business is subject to risks related to, among other factors, tariffs and other trade protection measures put in place by the United States or other countries, as well as U.S. international trade relations, including those with China and the European Union.
22
Starting in early 2025, the United States government announced reciprocal tariffs on imported goods from numerous countries. In response, certain foreign governments imposed tariffs on imported American goods. The United States government shortly thereafter declared a 90-day suspension of reciprocal tariffs and implemented a 10% tariff on all imports, except for those from China, which are subject to a higher tariff. Approximately 50% of the Company’s total net sales are generated in the United States. While most products are manufactured domestically, tariffs may affect demand, raise product costs, or disrupt the supply chain. Considerable uncertainty regarding the final resolution of tariffs remain, however, the Company is assessing the impact and what measures can be taken to mitigate their effects.
Orders and Backlog
Orders and backlog are not measures defined by accounting principles generally accepted in the United States of America ("GAAP") and our methodology for determining orders and backlog may vary from the methodology used by other companies. Management uses orders and backlog for capacity and resource planning. The Company believes this information is useful to investors to provide an indication of future revenues. Backlog represents the dollar value of orders which are expected to be recognized in net sales in the future. Orders are included in backlog when an executed binding contract with a price that has a floor has been received but has not been recognized in net sales.
Orders for the three months ended March 31, 2025 increased 10.1% to $610.3 million from $554.1 million for the same period in 2024. The increase was primarily attributable to higher demand in the Americas segment and tower product offerings in the EURAF segment. Orders were unfavorably impacted by $5.9 million from changes in foreign currency exchange rates.
As of March 31, 2025, total backlog was $797.8 million, a 22.7% increase from the December 31, 2024 backlog of $650.2 million, and a 17.9% decrease from the March 31, 2024 backlog of $971.3 million. Backlog was favorably impacted by $9.3 million and $0.4 million from December 31, 2024 and March 31, 2024, respectively, from changes in foreign currency exchange rates.
Results of Operations for the three months ended March 31, 2025 and 2024:
Three Months Ended
March 31,
2025
2024
Percentage Change
Net sales
$
470.9
$
495.1
(4.9
)%
Gross profit
89.8
92.5
(2.9
)%
Gross profit %
19.1
%
18.7
%
Engineering, selling, and administrative
expenses
82.9
76.0
9.1
%
Interest expense
8.7
9.2
(5.4
)%
Provision (benefit) for income taxes
(2.5
)
1.9
*
*Measure not meaningful
Net Sales
Consolidated net sales for the three months ended March 31, 2025 decreased 4.9% to $470.9 million from $495.1 million for the same period in 2024. This decrease was primarily attributable to $39.6 million of lower new machine sales in all segments as a result of product mix. This was partially offset by $15.4 million of higher non-new machine sales primarily in the Americas and EURAF segments. Net sales were unfavorably impacted by $5.7 million from changes in foreign currency exchange rates.
Gross Profit
Gross profit for the three months ended March 31, 2025 decreased 2.9% to $89.8 million from $92.5 million for the same period in 2024. This decrease was primarily due to lower net sales and lower absorbed costs due to lower manufacturing volume in the Americas segment, partially offset by favorable product mix. Gross profit was unfavorably impacted by $1.1 million from changes in foreign currency exchange rates.
23
Gross profit percentage increased in the three months ended March 31, 2025 to 19.1% from 18.7% for the same period in 2024. This increase was primarily due to favorable product mix, partially offset by lower absorbed costs due to lower manufacturing volume in the Americas segment.
Engineering, Selling, and Administrative Expenses
Engineering, selling, and administrative expenses for the three months ended March 31, 2025 increased 9.1% to $82.9 million from $76.0 million for the same period in 2024. The increase was primarily due to costs for the triennial bauma trade show, higher professional services fees, and higher new product development costs. Engineering, selling, and administrative expenses were favorably impacted by $1.4 million from changes in foreign currency exchange rates.
Interest Expense
Interest expense for the three months ended March 31, 2025 decreased 5.4% to $8.7 million from $9.2 million for the same period in 2024. The decrease was primarily due to lower average debt and lower interest rates on borrowings from the Company’s ABL revolving credit facility.
Provision (benefit) for Income Taxes
For the three months ended March 31, 2025 and 2024, the Company recorded a benefit for income taxes of $2.5 million and a provision for income taxes of $1.9 million, respectively. Changes to jurisdictional mix and a year-to-date loss before income taxes resulted in a benefit for income taxes for the three months ended March 31, 2025 as compared to the prior year’s provision for income taxes. In addition, the Company’s effective tax rate varies from the U.S. federal statutory rate of 21% due to results of foreign operations that are subject to income taxes at different statutory rates and losses in certain jurisdictions where no tax benefit can be realized.
Segment Operating Performance
The Company manages its business primarily on a geographic basis. The Company has three reportable segments: the Americas segment, EURAF segment, and MEAP segment. Further information regarding the Company’s reportable segments can be found in Note 17, “Segments,” to the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.
Three Months Ended
March 31,
2025
2024
Dollar Change
Percentage Change
Net Sales
Americas
$
259.3
$
283.2
$
(23.9
)
(8.4
)%
EURAF
145.6
143.0
2.6
1.8
%
MEAP
66.0
68.9
(2.9
)
(4.2
)%
Segment Operating
Income (Loss)
Americas
$
17.7
$
29.5
$
(11.8
)
(40.0
)%
EURAF
(11.3
)
(11.8
)
0.5
(4.2
)%
MEAP
11.4
8.2
3.2
39.0
%
*Measure not meaningful
Americas
Americas segment net sales decreased 8.4% for the three months ended March 31, 2025 to $259.3 million from $283.2 million for the same period in 2024. The decrease was primarily attributable to $31.2 million of lower new machine sales, partially offset by $7.5 million of higher non-new machine sales.
Americas segment operating income decreased 40.0% for the three months ended March 31, 2025 to $17.7 million from $29.5 million for the same period in 2024. The decrease was primarily due to lower net sales, lower absorbed costs due to lower manufacturing volume, and higher engineering, selling, and administrative expenses.
24
EURAF
EURAF segment net sales increased 1.8% for the three months ended March 31, 2025 to $145.6 million from $143.0 million for the same period in 2024. The increase was primarily due to higher tower crane sales and $10.2 million of higher non-new machine sales mainly from higher used crane sales. This was partially offset by $7.7 million of lower new machine sales, mainly due to a lower number of mobile crane shipments. Segment net sales were unfavorably impacted by $3.2 million from changes in foreign currency exchange rates.
EURAF segment operating loss remained relatively flat at $11.3 million for the three months ended March 31, 2025 as compared to $11.8 million for the same period in 2024. Segment operating income was favorably impacted by $0.4 million from changes in foreign currency exchange rates.
MEAP
MEAP segment net sales remained relatively flat at $66.0 million for the three months ended March 31, 2025 as compared to $68.9 million for the same period in 2024. Segment net sales were unfavorably impacted by $2.2 million from changes in foreign currency exchange rates.
MEAP segment operating income increased 39.0% for the three months ended March 31, 2025 to $11.4 million from $8.2 million for the same period in 2024. The increase was primarily due to higher absorbed costs. Segment operating income was unfavorably impacted by $0.4 million from changes in foreign currency exchange rates.
Financial Condition
Cash Flows
A summary of cash flows for the three months ended March 31, 2025 and 2024 are as follows:
Three Months Ended
March 31,
2025
2024
Net cash provided by (used for) operating activities
$
12.9
$
(30.6
)
Net cash used for investing activities
(23.6
)
(12.0
)
Net cash provided by financing activities
3.2
40.2
Cash and cash equivalents
41.4
31.5
C
ash Flows From Operating Activities
Net cash provided by operating activities of $12.9 million for the three months ended March 31, 2025 increased $43.5 million from net cash used for operating activities of $30.6 million for the same period in 2024. This increase in net cash provided by operating activities was primarily due to $55.2 million of lower cash use from changes in operating assets and liabilities. The lower cash use was primarily due to $23.1 million of lower cash outflows for inventory, $21.8 million of additional cash provided by accounts payable, accrued expenses, and other liabilities, and $11.7 million of additional cash provided by accounts receivable when compared to the prior year. This was partially offset by lower net income (loss) adjusted for non-cash items.
Cash Flows From Investing Activities
Net cash used for investing activities of $23.6 million for the three months ended March 31, 2025 increased $11.6 million from $12.0 million for the same period in 2024. The increase in net cash used for investing activities was primarily due to $12.9 million of cash outflows related to the purchase of certain assets and territory from Ring Power Corporation.
Cash Flows From Financing Activities
Net cash provided by financing activities of $3.2 million for the three months ended March 31, 2025 decreased $37.0 million from $40.2 million for the same period in 2024. The decrease in net cash provided by financing activities was primarily driven by $15.0 million of payments on the revolving credit facility in the current year and $25.8 million of lower proceeds from other debt - net when compared to the prior year. This is partially offset by $3.9 million of additional proceeds from the revolving credit facility when compared to the prior year.
25
Liquidity and Capital Resources
The Company’s liquidity position as of March 31, 2025 and December 31, 2024 is summarized as follows:
March 31, 2025
December 31, 2024
Cash and cash equivalents
$
41.4
$
48.0
Revolver borrowing capacity
325.0
325.0
Other debt availability
44.2
42.4
Less: Borrowings on revolver
(83.3
)
(79.0
)
Less: Borrowings on other debt
(16.8
)
(12.1
)
Less: Outstanding letters of credit
(3.4
)
(3.4
)
Total liquidity
$
307.1
$
320.9
The Company believes its liquidity and expected cash flows from operations are sufficient to meet expected working capital, capital expenditure, and other general ongoing operational needs in the subsequent twelve months.
Cash Sources
The Company has historically relied primarily on cash flows from operations, borrowings under revolving credit facilities, issuances of notes and other forms of debt financing as its sources of cash.
The maximum availability under the Company’s current ABL Revolving Credit Facility is $325.0 million, of which $100.0 million is available to our German subsidiary. The borrowing capacity under the ABL Revolving Credit Facility is based on the value of inventory, accounts receivable, and certain fixed assets of the Loan Parties. The Loan Parties’ obligations under the ABL Revolving Credit Facility are secured on a first-priority basis, subject to certain exceptions and permitted liens, by substantially all of the personal property and fee-owned real property of the Loan Parties. The liens securing the ABL Revolving Credit Facility are senior in priority to the second-priority liens securing the obligations under the 2031 Notes and the related guarantees. The ABL Revolving Credit Facility has a maturity date of September 18, 2029, and includes a $75.0 million letter of credit sub-facility, $10.0 million of which is available to the Company's German subsidiary that is a borrower under this facility.
In addition to the ABL Revolving Credit Facility, the Company has access to committed and non-committed lines of credit to fund working capital in Europe and China. There are six facilities, of which five facilities are denominated in Euros totaling €37.0 million and one facility denominated in Chinese Yuan totaling ¥30.0 million. Total U.S. dollar availability as of March 31, 2025 for the six overdraft facilities is $44.2 million, with $16.8 million outstanding.
Debt
Outstanding debt as of March 31, 2025 and December 31, 2024 is summarized as follows:
March 31, 2025
December 31, 2024
Borrowing under senior secured asset based
revolving credit facility
$
83.3
$
79.0
Senior secured second lien notes due 2031
300.0
300.0
Other debt
20.7
16.4
Deferred financing costs
(5.0
)
(5.2
)
Total debt
399.0
390.2
Short-term borrowings and current portion of long-term
debt
(17.6
)
(13.1
)
Long-term debt
$
381.4
$
377.1
Both the ABL Revolving Credit Facility and 2031 Notes include customary covenants and events of default. Refer to Note 11, “Debt,” to the Condensed Consolidated Financial Statements for additional discussions of the covenants for the ABL Revolving Credit Facility and the 2031 Notes. As of March 31, 2025, the Company was in compliance with all affirmative and negative covenants in its debt instruments, inclusive of the financial covenants pertaining to the ABL Revolving Credit Facility and 2031 Notes. Based upon management’s current plans and outlook, the Company believes it will be able to comply with these covenants during the subsequent twelve months. From time to time, the Company seeks to opportunistically raise capital in the debt capital markets and bank credit markets.
26
Non-GAAP Measures
The Company uses EBITDA, adjusted EBITDA, adjusted operating income, Adjusted ROIC, and free cash flows, which are financial measures that are not prepared in accordance with GAAP, as additional metrics to evaluate the Company’s performance. The Company believes these non-GAAP measures provide important supplemental information to readers regarding business trends that can be used in evaluating its results because these financial measures provide a consistent method of comparing financial performance and are commonly used by investors to assess performance. These non-GAAP financial measures should be considered together with, and are not substitutes for, the GAAP financial information provided herein.
Adjusted ROIC
Adjusted ROIC measures how efficiently the Company uses invested capital in its operations. Adjusted ROIC is not a measure defined by GAAP and the Company’s methodology for determining Adjusted ROIC may vary from the methodology used by other companies. Management and the Board of Directors use Adjusted ROIC as a measure to assess operational performance and capital allocation. The Company believes this information is useful to investors as it provides a measure of value creation as a percentage of capital invested.
Adjusted ROIC is determined by dividing adjusted net operating profit after tax (“Adjusted NOPAT”) for the trailing twelve-months ended by the five-quarter average of invested capital. Adjusted NOPAT is calculated by taking operating income plus the addback of amortization of intangible assets and the addback or subtraction of restructuring expenses, other non-recurring items - net, and provision for income taxes, which is determined using a 15% tax rate. Invested capital is defined as net total assets less cash and cash equivalents and income tax assets - net plus short-term and long-term debt. Income taxes are defined as income tax payables/receivables, net deferred tax assets/liabilities, and uncertain tax positions.
The Company’s Adjusted ROIC as of March 31, 2025 was 5.1%. Below is the calculation of Adjusted ROIC as of March 31, 2025.
Three Months Ended
March 31, 2025
December 31, 2024
September 30, 2024
June 30, 2024
Trailing Twelve Months
Operating income
$
5.3
$
16.2
$
7.5
$
12.9
$
41.9
Amortization of intangible assets
0.8
0.7
0.7
0.8
3.0
Restructuring expense
0.8
1.2
0.5
2.3
4.8
Other non-recurring items - net
(1)
—
1.0
2.6
5.4
9.0
Adjusted operating income
6.9
19.1
11.3
21.4
58.7
Provision for income taxes at 15%
(1.0
)
(2.9
)
(1.7
)
(3.2
)
(8.8
)
Adjusted NOPAT
$
5.9
$
16.2
$
9.6
$
18.2
$
49.9
March 31, 2025
December 31, 2024
September 30, 2024
June 30, 2024
March 31, 2024
5-Quarter Average
Total assets
$
1,763.8
$
1,660.0
$
1,776.7
$
1,747.9
$
1,780.6
1,745.8
Total liabilities
(1,112.2
)
(1,019.9
)
(1,169.1
)
(1,155.6
)
(1,184.6
)
(1,128.3
)
Net total assets
651.6
640.1
607.6
592.3
596.0
617.5
Cash and cash equivalents
(41.4
)
(48.0
)
(22.9
)
(38.1
)
(31.5
)
(36.4
)
Short-term borrowings and current portion
of long-term debt
17.6
13.1
40.5
21.4
42.5
27.0
Long-term debt
381.4
377.1
426.7
406.3
372.7
392.8
Income tax assets - net
(69.4
)
(66.9
)
(10.1
)
(4.4
)
(3.4
)
(30.8
)
Invested capital
$
939.8
$
915.4
$
1,041.8
$
977.5
$
976.3
$
970.2
Adjusted ROIC
5.1
%
(1) Other non-recurring items – net for the trailing twelve months relate to $8.9 million of costs associated with a legal matter with the U.S. EPA and $0.1 million of one-time costs. Refer to the Company’s previously filed Form 10-K and Form 10-Qs for a description of other non-recurring items - net for the three months ended December 31, 2024, September 30, 2024, and June 30, 2024.
EBITDA and Adjusted EBITDA
27
The Company defines EBITDA as net income (loss) before interest, taxes, depreciation, and amortization. The Company defines adjusted EBITDA as EBITDA plus the addback or subtraction of restructuring expense, other income (expense) - net, and certain other non-recurring items.
The reconciliation of net income (loss) to EBITDA and further to adjusted EBITDA for the three months ended March 31, 2025 and 2024, is summarized as follows:
Three Months Ended
March 31,
Trailing Twelve
2025
2024
Months
Net income (loss)
$
(6.3
)
$
4.5
$
45.0
Interest expense and amortization of deferred
financing fees
9.1
9.5
39.3
Provision (benefit) for income taxes
(2.5
)
1.9
(48.5
)
Depreciation expense
14.8
14.7
60.1
Amortization of intangible assets
0.8
0.7
3.0
EBITDA
15.9
31.3
98.9
Restructuring expense
0.8
0.6
4.8
Other non-recurring items - net
(1)
—
0.1
9.0
Other (income) expense - net
(2)
5.0
(0.7
)
6.1
Adjusted EBITDA
$
21.7
$
31.3
$
118.8
Adjusted EBITDA margin percentage
4.6
%
6.3
%
5.5
%
(1)
Other non-recurring items - net for the three months ended March 31, 2024 relate to $0.1 million of one-time costs. Other non-recurring items - net for the trailing twelve months relate to $8.9 million of costs associated with a legal matter with the U.S. EPA and $0.1 million of one-time costs.
(2)
Other (income) expense - net includes net foreign currency gains (losses), other components of net periodic pension costs, and other items in the three and trailing twelve months ended March 31, 2025 and the three months ended March 31, 2024.
Free Cash Flows
Free cash flows is defined as net cash provided by (used for) operating activities less cash outflow from investment in capital expenditures. The reconciliation of net cash provided by (used for) operating activities to free cash flows for the three months ended March 31, 2025 and 2024 are summarized as follows:
Three Months Ended
March 31,
2025
2024
Net cash provided by (used for) operating activities
$
12.9
$
(30.6
)
Capital expenditures
(10.8
)
(12.2
)
Free cash flows
$
2.1
$
(42.8
)
Critical Accounting Policies
The Company’s critical accounting policies have not materially changed since the 2024 Annual Report on Form 10-K was filed. Refer to the Critical Accounting Policies in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Annual Report on Form 10-K for the year ended December 31, 2024 for information about the Company’s policies, methodology and assumptions related to critical accounting policies.
Item 3. Quantitative and Qualita
tive Disclosure about Market Risk
The Company’s market risk disclosures have not materially changed since the 2024 Annual Report on Form 10-K was filed. The Company’s quantitative and qualitative disclosures about market risk are incorporated by reference from Part II, Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
28
Item 4. Controls
and Procedures
Disclosure Controls and Procedures:
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, and that such information is accumulated and communicated to the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely discussions regarding required disclosure.
Changes in Internal Control Over Financial Reporting:
The Company's management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). During the period covered by this report, the Company made no changes that have materially affected, or that are reasonably likely to materially affect, its internal control over financial reporting.
29
PART II. OTHE
R INFORMATION
Item 1A. Ri
sk Factors
There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the Securities and Exchange Commission on February 21, 2025.
Item 5. Other Information
(c) During the three months ended March 31, 2025
, no director or Section 16 officer of the Company adopted a "
Rule 10b5-1 trading arrangement
" or "
non-Rule 10b5-1 trading arrangement
", as each term is defined in Item 408 of Regulation S-K.
Inline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
Cover Page Interactive Data File (embedded within the Inline XBRL document)
X
(1)
(1) Filed Herewith
(2) Furnished Herewith
30
SIGNAT
URES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: May 7, 2025
The Manitowoc Company, Inc.
(Registrant)
/s/ Aaron H. Ravenscroft
Aaron H. Ravenscroft
President and Chief Executive Officer
(Principal Executive Officer and Director)
/s/ Brian P. Regan
Brian P. Regan
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
/s/ Ryan M. Palmer
Ryan M. Palmer
Vice President, Corporate Controller and Principal Accounting Officer
Insider Ownership of MANITOWOC CO INC
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of MANITOWOC CO INC
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)
